NCT06136767Recruiting
Registry for Systemic Eczema Treatments
Source: ClinicalTrials.gov · Last updated 7 Apr 2026
Brief summary (registry, in English)
The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 6 Nov 2023
- Start date
- 17 Jan 2024
- Primary completion date
- 31 Aug 2030
- Lead sponsor
- Johns Hopkins University
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT06136767
What you commit to
- Study type: Observational
- Planned participants: 400
- From 17 Jan 2024 to the primary completion date, 31 Aug 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Has not received clinical care at Johns Hopkins since 1/1/2017
Age
- Age ≥26 years old at the time of registry enrollment
- If \<18 years old, has a primary caretaker who does not speak English
- If \<18 years old, parent/legal guardian is unwilling to sign the written informed consent
Other
- Does not speak English
- Is a foster child
Who the study is looking for
- Age \<26 years old
- Current physician diagnosis of atopic dermatitis
- Provide signed informed consent if ≥ 18 years old
- Provide signed informed consent by parent or legal guardian (if \<18 years old) and informed assent if applicable
- Subject and/or parent/legal guardian is willing to be contacted in the future by study staff
- Seen for clinical care at Johns Hopkins since 1/1/2017
- Previously on, currently on, or planning to initiate (within next 6 months) a systemic AD therapy
Age in the registry: 1 year to 26 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins University Coordinator of this site? Confirm its status | Baltimore | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.